These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 13740465)

  • 21. The effect of Pitressin on cardiac output coronary, hepatic, and intestinal blood flow.
    DRAPANAS T; CROWE CP; SHIM WK; SCHENK WG
    Surg Gynecol Obstet; 1961 Oct; 113():484-9. PubMed ID: 13724273
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of vasopressin on sodium transfer by rat colon in vitro.
    AULSEBROOK KA
    Endocrinology; 1961 Jun; 68():1063-5. PubMed ID: 13685158
    [No Abstract]   [Full Text] [Related]  

  • 23. Differential effects of Pitressin on blood flow and oxygen extraction in canine vascular beds.
    Steckel RJ; Kolin A; MacAlpin RN; Snow HD; Juillard GF; Tesler AS; Metzger J
    AJR Am J Roentgenol; 1978 Jun; 130(6):1025-32. PubMed ID: 418635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of pitressin on the peripheral circulation.
    de Langen CD
    Bibl Anat; 1965; 7():77-80. PubMed ID: 5860800
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on the site of action of vasopressin in inducing adrenocorticotropin secretion.
    Yasuda N; Greer MA; Greer SE; Panton P
    Endocrinology; 1978 Sep; 103(3):906-11. PubMed ID: 217660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antidiuretic hormone and lipolysis.
    Bartsokas K; Polychronopoulou-Trichopolou A; Kouvelas ED; Charissiadou A; Valsamakis S; Kalaitzidou C
    Endokrinologie; 1975 Jan; 64(2):201-4. PubMed ID: 1149694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of lidoflazine (1-(4,4-bis-(p. flurophenyl)-butyl)-4-(2,6-dimethylanilino-carbonyl)-methyl piperazine) on the ECG changes induced with pitressin in rats].
    Setti L; Razzaboni G
    Boll Soc Ital Biol Sper; 1969 Sep; 45(18):1192-3. PubMed ID: 5387389
    [No Abstract]   [Full Text] [Related]  

  • 28. [Aldosterone excretion and electrolyte metabolism under the action of Pitressin in non-hydrated, normal human volunteers].
    FRANKEN FH; IRMSCHER K; DAWEKE H
    Acta Endocrinol (Copenh); 1961 Sep; 38():22-30. PubMed ID: 13701416
    [No Abstract]   [Full Text] [Related]  

  • 29. [A case of pitressin-sensitive diabetes insipidus].
    Rev Port Pediatr Pueric; 1966 May; 29(5):184-90. PubMed ID: 5914446
    [No Abstract]   [Full Text] [Related]  

  • 30. [The clinical and experimental pharmacology of vasopressin agonists and antagonists].
    Rudichenko VM
    Eksp Klin Farmakol; 1994; 57(2):68-73. PubMed ID: 8205056
    [No Abstract]   [Full Text] [Related]  

  • 31. The relationship between the vascular responses to the peptides angiotensin and pitressin.
    Louis WJ; Doyle AE
    Clin Sci; 1966 Oct; 31(2):255-63. PubMed ID: 4289109
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparative studies on the effect of ADH, hypertensin and renin on the renal excretion of water and electrolytes in the rat].
    SCHROEDER R; MEYER-BURGDORFF C; ROTT D; BRAHMS O
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1961; 240():285-312. PubMed ID: 13748680
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antagonistic action of reserpine and bretylium against electrocardiographic changes induced with pitressin in rats].
    Setti L; Razzaboni G; Vitolo A
    Boll Soc Ital Biol Sper; 1969 Apr; 45(7):414-6. PubMed ID: 5355877
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of vasopressin on sodium, potassium and water distribution in rat gastrocnemius muscle.
    FRIEDMAN SM; SRETER FA
    Endocrinology; 1961 Aug; 69():386-8. PubMed ID: 13702034
    [No Abstract]   [Full Text] [Related]  

  • 35. [Beta-adrenolytic and electrocardiographic effects using pitressin].
    Marmo E; Coscia L; Aulisio GA
    Angiologica; 1967; 4(5):256-70. PubMed ID: 4157291
    [No Abstract]   [Full Text] [Related]  

  • 36. [Action of pitressin on intrahepatic portal resistance in the isolated liver].
    Lambilliotte JP; Norman JC
    Rev Fr Etud Clin Biol; 1968 Mar; 13(3):289-92. PubMed ID: 5682077
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pharmacology and action mechanism of vasopressin as a regulator factor of blood pressure].
    Hirai A; Yoshida S
    Nihon Rinsho; 1992 Apr; 50 Suppl():84-9. PubMed ID: 1635267
    [No Abstract]   [Full Text] [Related]  

  • 38. [Chorionic gonadotropin and coronary circulation: inhibition of coronary spasm caused by pitressin].
    De Gregorio G; Buda A
    Boll Soc Ital Biol Sper; 1964 Dec; 40(24):1718-21. PubMed ID: 5877914
    [No Abstract]   [Full Text] [Related]  

  • 39. [Intravenous administration of synthetic lysine-8-vasopressin and oxytocin. Effects on blood levels of growth hormone, follicle-stimulating hormone and insulin].
    Kleinknecht D; Rosselin G; Tchobroutsky G; Dolais J
    Presse Med (1893); 1969 May; 77(23):856-8. PubMed ID: 5806688
    [No Abstract]   [Full Text] [Related]  

  • 40. [The blocking effect of adrenaline on the thyroid-stimulating effect of vasopressin in rats].
    Krasnovskaia IA; Voropanova LS; Polenov AL
    Biull Eksp Biol Med; 1993 Feb; 115(2):142-4. PubMed ID: 8043787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.